ArticleHuman vaccines & immunotherapeutics2026
Longitudinal assessment of influenza vaccination coverage in Spain: The "Gripómetro" as a real-time monitoring tool.
Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Influenza Vaccination as Cardiovascular Prevention in Adults with Heart Disease.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Delayed availability of vaccine coverage statistics can limit within-season situational awareness for seasonal influenza vaccination campaigns. This longitudinal ecological study evaluated influenza vaccination coverage (IVC) in Spain across five seasons (2018/19 to 2022/23) using the real-time monitoring tool Gripómetro, based on weekly landline telephone interviews conducted for six consecutive weeks starting 14 d after campaign launch. Adults aged 18-80 y from the Spanish population and healthcare workers (HCWs) from public primary care centers were surveyed using a semi-structured questionnaire. An overall IVC increase was observed during the COVID-19 pandemic, peaking in the 2020/21 season. Among individuals aged ≥65 y, coverage rose from 56% in 2018/19 to 68% in 2020/21 and remained stable thereafter, below the European stablished target 75%. In 2020/21, a coverage peak (49%) was observed among at-risk adults <65 y, followed by a decline. HCWs achieved 74% IVC during the pandemic, with a smaller decline in subsequent seasons. Despite increased coverage, ~80%-85% of respondents still perceived influenza as a mild illness. However, adherence improved over time, with more participants identifying as "Faithful" to vaccination and fewer as "Not convinced." The Gripómetro provided early, within-season coverage estimates that closely tracked official national data for older adults and can complement delayed administrative reporting. The findings highlight the positive influence of the pandemic on vaccination uptake, and the importance of sustained public health efforts to maintain influenza risk awareness and preserve high IVC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.